Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2009
06/30/2009CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
06/30/2009CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
06/30/2009CA2095521C Hepatitis c virus asialoglycoproteins
06/30/2009CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
06/25/2009WO2009079452A2 Treatment and prevention of hiv infection
06/25/2009WO2009079412A2 Reverse transcriptase inhibitors
06/25/2009WO2009078820A1 Cationic core-shell peptide nanoparticles
06/25/2009WO2009078799A1 New vaccine for the treatment of mycobacterium related disorders
06/25/2009WO2009078798A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
06/25/2009WO2009078447A1 Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents
06/25/2009WO2009077989A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives
06/25/2009WO2009077954A1 Aminopyrazole derivatives
06/25/2009WO2009077854A2 Adjuvanted glucans
06/25/2009WO2009077844A2 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
06/25/2009WO2009077586A2 Methods and compositions for the preparation and use of toxin conjugates
06/25/2009WO2009077497A2 Azolyl methyl oxiranes, the use thereof, and agents containing them
06/25/2009WO2009077485A2 1(2)h-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
06/25/2009WO2009077484A2 A cyano piperidinyl-phenil-oxazolidinone and use thereof.
06/25/2009WO2009077471A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077443A2 Azolylmethyloxiranes, use thereof and agents containing the same
06/25/2009WO2009077352A1 Prevention of opportunistic infections in immune-compromised subjects
06/25/2009WO2009076824A1 Genes encoding major capsid protein l1 of human papilloma virus's
06/25/2009WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
06/25/2009WO2009076775A1 Immune response modulation and uses thereof
06/25/2009WO2009076747A1 Viral polymerase inhibitors
06/25/2009WO2009076694A1 Treatment of inflammatory illnesses with ace2
06/25/2009WO2009060122A3 Use of oligonucleotides with modified bases as antiviral agents
06/25/2009WO2009048839A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
06/25/2009WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine
06/25/2009WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent
06/25/2009WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent
06/25/2009WO2009040021A3 Use of a peptide as a therapeutic agent
06/25/2009WO2009037362A9 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection
06/25/2009WO2009033746A3 Use of a peptide as a therapeutic agent
06/25/2009WO2009019230A4 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
06/25/2009WO2009013480A3 Antibacterial combination therapy
06/25/2009WO2009000825A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
06/25/2009US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma
06/25/2009US20090163587 Ester prodrugs of prostratin and related phorbol compounds
06/25/2009US20090163556 Glycinamide derivatives as raf-kinase inhbitors
06/25/2009US20090163553 Benzimidazole compound crystal
06/25/2009US20090163533 1-Substituted Pyrazolo (3,4-C) Ring Compounds as Modulators of Cytokine Biosynthesis for the Treatment of Viral Infections and Neoplastic Diseases
06/25/2009US20090163532 Aqueous Gel Formulations Containing Immune Response Modifiers
06/25/2009US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis
06/25/2009US20090163496 Antibacterial agents
06/25/2009US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
06/25/2009US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor
06/25/2009US20090163490 Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors
06/25/2009US20090163484 Pharmaceuticals containing fluoroquinolones
06/25/2009US20090163478 Salts and Crystal Modifications Thereof
06/25/2009US20090163467 New compounds
06/25/2009US20090163444 Phospho-indoles as hiv inhibitors
06/25/2009US20090163422 Three-dimensional structure of the apobec 2 structure, uses thereof, and methods for treating chronic and infectious diseases
06/25/2009US20090163410 Novel Peptides and the Biological Use Thereof
06/25/2009US20090163409 Trappin-2 (elafin) inhibits HIV
06/25/2009US20090162867 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
06/25/2009US20090162399 Nef deleted human immunodeficiency virus for the restoration of T-lymphocyte signaling and activation for the treatment and prevention of human immunodeficiency virus infection
06/25/2009US20090162396 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
06/25/2009US20090162392 Mutant forms of streptolysin o
06/25/2009US20090162390 Molecular Scaffolds for HIV-1 Immunogens
06/25/2009US20090162383 Method for designing vaccines against constantly mutating pathogens
06/25/2009US20090162379 Inhibitors of S. aureus SdrD protein attachment to cells and uses therefor
06/25/2009US20090162378 Anti-human cytomegalovius antibodies
06/25/2009US20090162373 Materials and methods for treatment of hepatitis c
06/25/2009US20090162356 CRIg antagonists
06/25/2009US20090162319 Reverse transcriptase inhibitors
06/25/2009US20090162318 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
06/25/2009CA2709555A1 Treatment of inflammatory illnesses with ace2
06/25/2009CA2709396A1 Prevention of opportunistic infections in immune-compromised subjects
06/25/2009CA2709176A1 Reverse transcriptase inhibitors
06/25/2009CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
06/25/2009CA2708658A1 Treatment and prevention of hiv infection
06/25/2009CA2708324A1 Viral polymerase inhibitors
06/25/2009CA2707615A1 Azolylmethyloxiranes, their use and compositions comprising them
06/25/2009CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
06/25/2009CA2706837A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives
06/25/2009CA2706836A1 Aminopyrazole derivatives
06/25/2009CA2706617A1 Adjuvanted glucans
06/24/2009EP2072522A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes
06/24/2009EP2072514A1 1(2)H-tetrazol-5-yl-phenyl-oxazolidinones as antibacterial agents
06/24/2009EP2072513A1 A cyano piperidinyl-phenil-oxazolidinone and use thereof
06/24/2009EP2072052A1 Prevention of opportunistic infections in immune-compromised subjects
06/24/2009EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
06/24/2009EP1844004B1 Quinazoline derivates as antiviral agents
06/24/2009EP1590360A4 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
06/24/2009EP1451333B1 Ul16 binding protein 4
06/24/2009EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
06/24/2009EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it
06/24/2009EP1205559B1 Method for detecting pathogenic microorganisms and antimicrobial agents, method for evaluating the drug effect of antimicrobial agents, and antimicrobial agents
06/24/2009EP0935664B1 New systems for regulating genetic expression
06/24/2009CN100503829C Interleukin-18 mutants, their production and use
06/24/2009CN100503628C Modified fluorinated nucleoside analogues
06/24/2009CN100503608C Deazapurines and uses thereof
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/24/2009CN100503592C Anti-AIDS virus active substance desmosdumotin D and desmosdumotin and its analogue
06/24/2009CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors
06/24/2009CN100503572C Caspase inhibitors and uses thereof
06/24/2009CN100503560C Substituted cyclohexane derivatives
06/24/2009CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application
06/24/2009CN100502898C Honeysuckle extract, preparation and use thereof
1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 1798